5 research outputs found
Additional file 2: Table S1. of Aerosol delivery during invasive mechanical ventilation: a systematic review
Characteristics and results of the clinical studies. Table S2. Characteristics and results of the experimental studies. Table S3. Downs and Black score of the included studies. Table S4. Mechanical ventilation characteristics during inhalation. (DOCX 209 kb
Additional file 1: of Aerosol delivery during invasive mechanical ventilation: a systematic review
Complementary information related to the search strategy, selection criteria, data extraction and data expression. It also includes the full electronic search strategy (detailed search equation) for the Pubmed database. (DOCX 55 kb
Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine
National and international guidelines recommend droplet/airborne transmission and contact precautions for those caring for coronavirus disease 2019 (COVID-19) patients in ambulatory and acute care settings. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, an acute respiratory infectious agent, is primarily transmitted between people through respiratory droplets and contact routes. A recognized key to transmission of COVID-19, and droplet infections generally, is the dispersion of bioaerosols from the patient. Increased risk of transmission has been associated with aerosol generating procedures that include endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, noninvasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. The knowledge that COVID-19 subjects can be asymptomatic and still shed virus, producing infectious droplets during breathing, suggests that health care workers (HCWs) should assume every patient is potentially infectious during this pandemic. Taking actions to reduce risk of transmission to HCWs is, therefore, a vital consideration for safe delivery of all medical aerosols. Guidelines for use of personal protective equipment (glove, gowns, masks, shield, and/or powered air purifying respiratory) during high-risk procedures are essential and should be considered for use with lower risk procedures such as administration of uncontaminated medical aerosols. Bioaerosols generated by infected patients are a major source of transmission for SARS CoV-2, and other infectious agents. In contrast, therapeutic aerosols do not add to the risk of disease transmission unless contaminated by patients or HCWs
Additional file 1 of Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study
Additional file 1. Supplemental Figure 1. Receiver operating characteristic curves for platelet count increment and CCI. Supplementary Table 1. Details of surgery and invasive procedures requiring prophylactic platelet transfusion. Supplementary Tables 2 to 8. Sensitivity analyses in patients with and without hematology malignancy and chemotherapy
Additional file 1: of Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study
Outcome of patients admitted to the ICU for acute manifestation of small-vessel vasculitis. (DOCX 23 kb